CanAssist Breast

About CanAssist Breast

CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast provides information about the risk of recurrence of early-stage, hormone receptor-positive breast cancer patients. This test analyses critical biomarkers in the tumour to assess the risk of recurrence, and helps oncologists to personalize treatment plans.

Know Your Recurrence Risk

Recurrence risk prediction is an important step towards personalized cancer treatment. In up to 3 out of 4 early-stage hormone receptor-positive breast cancer patients, the benefit from chemotherapy is not outweighed by its risks.

Personalize Your Cancer Treatment

With vital insights gained through the results of CanAssist Breast, it is possible to identify the patient's risk of a cancer recurrence over five years. By understanding the tumour biology, the test calculates the risk of recurrence and classifies the patients as ‘low risk’ and ‘high risk’ using a machine learning statistical algorithm. This enables the doctors to personalize treatment for each individual, resulting in improved quality of life and better clinical outcomes.

Avoid Chemotherapy and it's Side Effects

CanAssist Breast can precisely identify the need for chemotherapy among early- stage breast cancer patients, by assessing their risk of recurrence. Chemotherapy takes a toll on both physical and mental health of patients undergoing treatment. It is primarily designed to target the fast-growing cancer cells. However, it also destroys healthy cells in its course, causing further debilitating side effects in the patients.

CanAssist Breast determines the patient’s risk of breast cancer recurrence over five years, classifying patients as ‘low-risk’ or ‘high-risk’ for cancer recurrence.The 'low-risk' patients’ can possibly avoid chemotherapy and its side effects and personalize their cancer treatment.

Some of these side effects include:

  • Hair loss
  • Anaemia
  • Nausea
  • Constipation/
    Diarrhea
  • Fatigue
  • Oral
    Infections
  • Kidney
    problems
  • Weight loss
  • Fertility
    Problems
  • Skin & Nail
    Allergy

Avoid Chemotherapy and it's Side Effects

Cancer cells multiply fast and chemotherapy-drugs are designed to kill these fast-growing cells. Unfortunately, these drugs pass through the entire body and kill all fast-growing cells including the healthy ones. This affects the internal functioning of the body, leading to further complications. Some of the significant side effects of chemotherapy include:

Hair loss
Anaemia
Nausea
Constipation/
Diarrhea
Fatigue
Oral
Infections
Kidney
problems
Weight loss
Fertility
Problems
Skin & Nail
Allergy

Am I Eligible?

The patients must meet the following criteria to take the CanAssist Breast test:

  • Patients with early-stage (Stage I or II), invasive breast cancer
  • Patients with hormone-receptor-positive (ER+/PR+) and HER2-negative disease
  • Patients with lymph node negative (NO) or up to three lymph nodes positive (N1) disease
  • Patients who have not gone through neo-adjuvant chemotherapy

If you meet the eligibility criteria, your doctor can prescribe CanAssist Breast post-surgery. Supported with the test results, your doctor can decide on how likely it is that you would benefit from addition of chemotherapy to your treatment plan.

*The test is not applicable for patients diagnosed with DCIS (Ductal Carcinoma In- Situ).

Want to know about your recurrence risk?

to personalize your cancer treatment and reduce the risk & side effects of chemotheraphy